Sun Pharma signs non-exclusive patent licensing agreement with Takeda for introducing Novel…
The new partnership aims to address widespread gastroesophageal reflux disease in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sun Pharma
Data shows durability of pain relief for patients with knee osteoarthritis (OA)
Data presented by Sun Pharma and Moebuis at EULAR 2024 from the Global Phase 2b clinical trial demonstrates the durability of pain…
Sun Pharma included in S&P Global Sustainability Yearbook 2024
Over 9,400 companies were assessed for The Sustainability Yearbook 2024. Out of these, 739 companies have qualified for inclusion…
Chandigarh Calling!
Pharma experts and leaders unite to unravel opportunities for India Pharma Inc and explore Chandigarh's potential to fuel India's…
NPPA slashes prices on 33 FDCs drugs
This move affects pharma companies like JB Chemicals, Eris Lifesciences, Zydus Healthcare, Cipla, Sun Pharma, Sanofi India, and…
A digital makeover: Rx for pharma’s success
As pharma industry undergoes a digital renaissance, industry leaders share insights on the pivotal role of technology in…
Sun Pharma, Zydus sign licensing pact to co-market Desidustat for CKD treatment in India
The drug will be marketed by Sun Pharma under the brand name RYTSTAT. Zydus continues to market the drug under the brand name…
LIC sells over two per cent stake in Sun Pharma for Rs 4,699 cr
Corporation's shareholding in Sun Pharma has decreased from 5.023 per cent to 3.012 per cent of the paid-up capital of the said…
Sun Pharma presents data from first-in-human phase 1 studies of GL0034
GL0034 (utreglutide) is an investigational novel glucagon-like peptide 1 receptor agonist (GLP- 1RA) in development as a…
Sun Pharma, Philogen sign pact to commercialise specialty product, NIDLEGY in Europe, Australia and…
Nidlegy, currently in Phase III clinical trials, is a new anti-cancer biopharmaceutical which is being developed by Philogen for…